Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -160.43% | 139.25% | -39.98% | 34.50% | 13.51% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -60.98% | 0.00% | 46.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.90% | -180.52% | 57.59% | -42.71% | -8.46% |
| Change in Net Operating Assets | -49.44% | 108.13% | -62.41% | 69.71% | 189.22% |
| Cash from Operations | -135.55% | 61.77% | -294.77% | 68.87% | 54.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -100.00% | -- |
| Total Debt Issued | -100.00% | -94.10% | 2,272.00% | -78.72% | -69.68% |
| Total Debt Repaid | -- | 100.00% | -- | 100.00% | -116.98% |
| Issuance of Common Stock | -- | -- | -- | -86.67% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -134.29% | -92.68% | 769.09% | -80.70% | -18.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 613.83% | -189.14% | 416.08% | -298.91% | 96.89% |